Feeley Kevin
SEC CIK 1944119 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| WGS | GeneDx Holdings Corp. | CFO | 48.7K | — | $15.79M | 132 | 2022-12-01 | 2026-09-16 |
Most active insiders at WGS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Meister Keith A. | Dir, 10% | $74.03M | — |
| 2 | Casdin Capital, LLC | Dir, 10% | $32.57M | — |
| 3 | Stueland Katherine | CEO, Dir | — | $12.90M |
| 4 | RUCH JOSHUA | Dir | — | $6.09M |
| 5 | Feeley Kevin | CFO | — | $4.07M |
| 6 | Dechairo Bryan | COO | — | $850.6K |
| 7 | Fuchs Thomas | Dir | — | — |
| 8 | Leproust Emily M. | Dir | — | — |
| 9 | Ryan Jason | Dir | — | — |
| 10 | Casdin Eli | Dir, 10% | — | — |
Transactions 132
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-18 16:39 | 2026-09-16 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +7,197 | 48.7K | +17% | $0 |
| DM | 2026-09-18 16:39 | 2026-09-16 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $97.61 | -3,728 | 44.9K | -8% | -$363.9K |
| D | 2026-09-11 16:10 | 2026-09-09 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +2,462 | 42.8K | +6% | $0 |
| D | 2026-09-11 16:10 | 2026-09-09 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $84.22 | -1,285 | 41.5K | -3% | -$108.2K |
| D | 2026-09-03 16:09 | 2026-09-01 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +717 | 40.7K | +2% | $0 |
| D | 2026-09-03 16:09 | 2026-09-01 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $83.84 | -372 | 40.3K | -0.9% | -$31.2K |
| D | 2026-06-18 16:11 | 2026-06-16 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +7,197 | 43.7K | +20% | $0 |
| DM | 2026-06-18 16:11 | 2026-06-16 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $60.77 | -3,729 | 40.0K | -9% | -$226.6K |
| D | 2026-06-11 16:12 | 2026-06-09 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +2,462 | 37.8K | +7% | $0 |
| D | 2026-06-11 16:12 | 2026-06-09 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $53.77 | -1,266 | 36.5K | -3% | -$68.1K |
| D | 2026-06-03 16:16 | 2026-06-01 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +717 | 35.7K | +2% | $0 |
| D | 2026-06-03 16:16 | 2026-06-01 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $51.74 | -369 | 35.3K | -1% | -$19.1K |
| D | 2026-05-01 16:24 | 2026-04-29 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +754 | 35.3K | +2% | $0 |
| D | 2026-05-01 16:24 | 2026-04-29 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $65.19 | -392 | 34.9K | -1% | -$25.6K |
| DM | 2026-03-30 | 2026-03-26 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $63.17 | -8,818 | 40.9K | -18% | -$557.0K |
| D | 2026-03-30 | 2026-03-26 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +16.2K | 43.4K | +60% | $0 |
| DM | 2026-03-17 | 2026-03-15+ | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +11.0K | 32.9K | +50% | $0 |
| DM | 2026-03-17 | 2026-03-16 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $76.80 | -5,706 | 30.5K | -16% | -$438.2K |
| D | 2026-03-11 | 2026-03-09 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $86.75 | -1,280 | 21.8K | -6% | -$111.0K |
| D | 2026-03-11 | 2026-03-09 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +2,462 | 23.1K | +12% | $0 |
| 2026-03-09 | 2026-03-06 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | A - Grant | $88.11 | +1,986 | 20.7K | +11% | +$175.0K | |
| D | 2026-03-05 | 2026-03-03 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | A - Grant | $0.00 | +15.3K | 24.9K | +159% | $0 |
| DM | 2026-03-05 | 2026-03-04 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale | $78.61 | -6,187 | 23.4K | -21% | -$486.4K |
| D | 2026-03-03 | 2026-03-01 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +718 | 9,886 | +8% | $0 |
| D | 2026-03-03 | 2026-03-02 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $77.52 | -287 | 9,599 | -3% | -$22.2K |
| DM | 2026-02-02 | 2026-01-29 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $93.99 | -317 | 9,170 | -3% | -$29.8K |
| D | 2026-02-02 | 2026-01-29 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +754 | 9,485 | +9% | $0 |
| DM | 2025-12-18 | 2025-12-16 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $143.87 | -3,855 | 8,884 | -30% | -$554.6K |
| D | 2025-12-18 | 2025-12-16 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +7,197 | 12.6K | +134% | $0 |
| D | 2025-12-11 | 2025-12-09 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +2,462 | 6,655 | +59% | $0 |
| D | 2025-12-11 | 2025-12-09 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $159.28 | -1,266 | 5,389 | -19% | -$201.6K |
| D | 2025-12-03 | 2025-12-01 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +717 | 4,570 | +19% | $0 |
| D | 2025-12-03 | 2025-12-01 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $162.54 | -377 | 4,193 | -8% | -$61.3K |
| D | 2025-10-31 | 2025-10-29 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $136.54 | -388 | 3,757 | -9% | -$53.0K |
| D | 2025-10-31 | 2025-10-29 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +753 | 4,145 | +22% | $0 |
| DM | 2025-10-01 | 2025-09-30 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $108.38 | -6,609 | 3,392 | -66% | -$716.3K |
| D | 2025-10-01 | 2025-09-30 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $32.67 | +1,246 | 10.0K | +14% | +$40.7K |
| A | 2025-09-18 | 2025-09-16 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +7,197 | 12.5K | +136% | $0 |
| D | 2025-09-18 | 2025-09-16 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $121.47 | -3,728 | 8,755 | -30% | -$452.8K |
| D | 2025-09-18 | 2025-09-16 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | -7,197 | 12.5K | -37% | $0 |
| DM | 2025-09-11 | 2025-09-09 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $128.05 | -1,272 | 5,286 | -19% | -$162.9K |
| D | 2025-09-11 | 2025-09-09 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +2,462 | 6,558 | +60% | $0 |
| D | 2025-09-03 | 2025-09-01 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +717 | 4,474 | +19% | $0 |
| D | 2025-09-03 | 2025-09-02 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $125.81 | -378 | 4,096 | -8% | -$47.6K |
| D | 2025-07-31 | 2025-07-29 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $105.31 | -388 | 3,757 | -9% | -$40.9K |
| D | 2025-07-31 | 2025-07-29 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +753 | 4,145 | +22% | $0 |
| D | 2025-07-11 | 2025-07-09 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $93.00 | -5,278 | 3,392 | -61% | -$490.9K |
| D | 2025-07-11 | 2025-07-09 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $32.67 | +1,245 | 8,670 | +17% | +$40.7K |
| M | 2025-07-03 | 2025-07-01 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale | $91.12 | -1,344 | 7,771 | -15% | -$122.5K |
| D | 2025-06-18 | 2025-06-16 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | -7,197 | 12.5K | -37% | $0 |
| D | 2025-06-18 | 2025-06-16 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $64.77 | -3,729 | 8,769 | -30% | -$241.5K |
| D | 2025-06-11 | 2025-06-09 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +2,462 | 6,567 | +60% | $0 |
| D | 2025-06-11 | 2025-06-09 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $72.55 | -1,266 | 5,301 | -19% | -$91.8K |
| D | 2025-06-03 | 2025-06-01 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +718 | 4,475 | +19% | $0 |
| D | 2025-06-03 | 2025-06-02 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $71.26 | -370 | 4,105 | -8% | -$26.4K |
| DA | 2025-05-09 | 2025-04-09 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $32.67 | +1,246 | 17.2K | +8% | +$40.7K |
| DMA | 2025-05-09 | 2025-04-09 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $92.06 | -14.3K | 16.6K | -46% | -$1.31M |
| D | 2025-05-01 | 2025-04-29 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +753 | 3,725 | +25% | $0 |
| D | 2025-05-01 | 2025-04-30 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | A - Grant | $56.82 | +420 | 3,757 | +13% | +$23.9K |
| D | 2025-05-01 | 2025-04-29 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $113.09 | -388 | 3,337 | -10% | -$43.9K |
| DM | 2025-04-10 | 2025-04-09 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $92.18 | -15.5K | 14.0K | -53% | -$1.43M |
| D | 2025-04-10 | 2025-04-09 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $32.67 | +1,246 | 17.2K | +8% | +$40.7K |
| DM | 2025-03-28 | 2025-03-26 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $95.61 | -8,746 | 16.3K | -35% | -$836.2K |
| D | 2025-03-28 | 2025-03-26 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +16.2K | 24.7K | +191% | $0 |
| D | 2025-03-17 | 2025-03-16 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | -7,197 | 12.2K | -37% | $0 |
| DM | 2025-03-17 | 2025-03-13+ | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $96.07 | -4,151 | 5,044 | -45% | -$398.8K |
| D | 2025-03-11 | 2025-03-10 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $94.72 | -922 | 5,446 | -14% | -$87.3K |
| D | 2025-03-11 | 2025-03-09 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +2,462 | 6,368 | +63% | $0 |
| D | 2025-03-04 | 2025-03-01 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +717 | 4,167 | +21% | $0 |
| D | 2025-03-04 | 2025-03-03 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $103.94 | -261 | 3,906 | -6% | -$27.1K |
| D | 2025-01-31 | 2025-01-29 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +753 | 3,225 | +30% | $0 |
| D | 2025-01-31 | 2025-01-29 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $78.48 | -275 | 2,950 | -9% | -$21.6K |
| DM | 2025-01-10 | 2025-01-07 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $93.82 | -35.5K | 2,472 | -93% | -$3.33M |
| D | 2025-01-10 | 2025-01-07 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $32.67 | +11.2K | 38.0K | +42% | +$366.2K |
| M | 2025-01-06 | 2025-01-02 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale | $76.04 | -1,430 | 27.9K | -5% | -$108.7K |
| D | 2024-12-18 | 2024-12-16 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $76.75 | -3,728 | 28.2K | -12% | -$286.1K |
| D | 2024-12-18 | 2024-12-16 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +7,197 | 31.9K | +29% | $0 |
| D | 2024-12-11 | 2024-12-09 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $76.37 | -1,137 | 24.7K | -4% | -$86.8K |
| D | 2024-12-11 | 2024-12-09 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +2,462 | 25.9K | +11% | $0 |
| D | 2024-12-03 | 2024-12-01 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +718 | 23.7K | +3% | $0 |
| D | 2024-12-03 | 2024-12-02 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $78.39 | -263 | 23.4K | -1% | -$20.6K |
| M | 2024-11-25 | 2024-11-21+ | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale | $74.81 | -22.0K | 44.3K | -33% | -$1.65M |
| D | 2024-10-31 | 2024-10-29 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +753 | 45.2K | +2% | $0 |
| D | 2024-10-31 | 2024-10-29 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $66.60 | -274 | 45.0K | -0.6% | -$18.2K |
| D | 2024-09-18 | 2024-09-16 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +7,197 | 47.1K | +18% | $0 |
| D | 2024-09-18 | 2024-09-16 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $37.59 | -2,635 | 44.5K | -6% | -$99.0K |
| D | 2024-09-11 | 2024-09-09 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $33.33 | -895 | 39.9K | -2% | -$29.8K |
| D | 2024-09-11 | 2024-09-09 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +2,462 | 40.8K | +6% | $0 |
| D | 2024-09-04 | 2024-09-01 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +717 | 38.6K | +2% | $0 |
| D | 2024-09-04 | 2024-09-03 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $31.71 | -262 | 38.3K | -0.7% | -$8,308 |
| D | 2024-07-31 | 2024-07-29 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +753 | 38.2K | +2% | $0 |
| D | 2024-07-31 | 2024-07-29 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $33.54 | -274 | 37.9K | -0.7% | -$9,190 |
| D | 2024-06-18 | 2024-06-16 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +7,197 | 40.1K | +22% | $0 |
| D | 2024-06-18 | 2024-06-17 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $28.31 | -2,646 | 37.4K | -7% | -$74.9K |
| D | 2024-06-11 | 2024-06-09 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +2,462 | 33.8K | +8% | $0 |
| D | 2024-06-11 | 2024-06-10 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $24.92 | -895 | 32.9K | -3% | -$22.3K |
| D | 2024-06-04 | 2024-06-03 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $20.55 | -262 | 31.3K | -0.8% | -$5,384 |
| D | 2024-06-04 | 2024-06-01 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +717 | 31.6K | +2% | $0 |
| D | 2024-04-30 | 2024-04-29 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | M - OptEx | $0.00 | +3,013 | 31.9K | +10% | $0 |
| D | 2024-04-30 | 2024-04-29 | WGS | GeneDx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $11.04 | -1,104 | 30.8K | -3% | -$12.2K |
Purchase Sale Sale after option exercise All abbreviations